Johnson & Johnson to Split Into 2 Public Companies

Johnson & Johnson announced plans to split into two publicly traded companies, separating its consumer products from its pharmaceutical and medical device operations. This move, the largest in its 135-year history, aims to better focus on each division's growth. The transaction is expected to be completed in 18 to 24 months. This decision follows similar actions by other large corporations like Toshiba and General Electric, highlighting a trend towards simplification. The company believes this separation is in the best long-term interest of its stakeholders.

What major change is Johnson & Johnson planning to implement?

• Merging with another company

• Splitting into two publicly traded companies

• Launching a new product line

• Closing its consumer products division

Which of the following brands will be part of the separated consumer products unit?

• Aveeno

• Stelara

• Tylenol

• Remicade

What is included in the fast-growing division that will remain with Johnson & Johnson?

• Prescription drugs and medical devices

• Cosmetic products

• Food and beverages

• Household cleaning products

How long does Johnson & Johnson expect the separation process to take?

• 6 to 12 months

• 12 to 18 months

• 18 to 24 months

• 24 to 30 months

Which other companies have made similar announcements to Johnson & Johnson's restructuring?

• Samsung and Sony

• Amazon and Google

• Toshiba and General Electric

• Apple and Microsoft